Caldwell Sutter Capital, Inc. Spruce Biosciences, Inc. Transaction History
Caldwell Sutter Capital, Inc.
- $215 Billion
- Q4 2024
A detailed history of Caldwell Sutter Capital, Inc. transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Caldwell Sutter Capital, Inc. holds 1,000 shares of SPRB stock, worth $300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$300
Previous $475,000
11.58%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SPRB
# of Institutions
32Shares Held
15.9MCall Options Held
0Put Options Held
0-
River Vest Venture Management LLC St. Louis, MO2.94MShares$880,88420.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$868,9551.19% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$782,7370.04% of portfolio
-
Abingworth LLP London, X01.79MShares$537,7550.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.05MShares$313,7480.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $7.07M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...